Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.
– On track to announce top-line results from Phase 2 CANYON trial of sevasemten in adults with Becker in December 2024 – – Advanced Phase 2 LYNX and FOX trials of sevasemten in children and...
Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced its participation at the 29th International Annual Congress of the World Muscle...
– In a Phase 1 in healthy subjects, EDG-7500 was well-tolerated without meaningful changes in left ventricle ejection fraction (LVEF) – – CIRRUS-HCM single-dose trial of EDG-7500 in obstructive...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.96 | -2.89505428227 | 33.16 | 33.21 | 29.8211 | 603998 | 31.37388766 | CS |
| 4 | -2.83 | -8.07878960891 | 35.03 | 38.12 | 29.8211 | 686716 | 34.12089201 | CS |
| 12 | 13.62 | 73.3046286329 | 18.58 | 38.12 | 16.6 | 1153580 | 28.36640196 | CS |
| 26 | 14.32 | 80.0894854586 | 17.88 | 38.12 | 15.0473 | 976044 | 23.89819774 | CS |
| 52 | 25.71 | 396.147919877 | 6.49 | 38.12 | 5.93 | 912549 | 19.66014299 | CS |
| 156 | 12.11 | 60.2787456446 | 20.09 | 38.12 | 5.12 | 469946 | 16.45082673 | CS |
| 260 | 5.2 | 19.2592592593 | 27 | 40.49 | 5.12 | 412005 | 16.96899259 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
